Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Between- and within-site variation in medication choices and adverse events during procedural sedation for electrical cardioversion of atrial fibrillation and flutter.

Clinkard D, Stiell I, Lang E, Rose S, Clement C, Brison R, Rowe BH, Borgundvaag B, Langhan T, Magee K, Stenstrom R, Perry JJ, Birnie D, Wells G, McRae A.

CJEM. 2017 Jun 7:1-7. doi: 10.1017/cem.2017.20. [Epub ahead of print]

PMID:
28587704
2.

Uncomplicated urinary tract infections in the emergency department: a review of local practice patterns.

Poon E, Self L, McLeod SL, Caine S, Borgundvaag B.

CJEM. 2017 Jun 7:1-6. doi: 10.1017/cem.2017.39. [Epub ahead of print]

PMID:
28587696
3.

Rates and predictive factors of return to the emergency department following an initial release by the emergency department for acute heart failure.

Claret PG, Calder LA, Stiell IG, Yan JW, Clement CM, Borgundvaag B, Forster AJ, Perry JJ, Rowe BH.

CJEM. 2017 Apr 3:1-8. doi: 10.1017/cem.2017.14. [Epub ahead of print]

PMID:
28367768
4.

Outcomes for Emergency Department Patients With Recent-Onset Atrial Fibrillation and Flutter Treated in Canadian Hospitals.

Stiell IG, Clement CM, Rowe BH, Brison RJ, Wyse DG, Birnie D, Dorian P, Lang E, Perry JJ, Borgundvaag B, Eagles D, Redfearn D, Brinkhurst J, Wells GA.

Ann Emerg Med. 2017 May;69(5):562-571.e2. doi: 10.1016/j.annemergmed.2016.10.013. Epub 2017 Jan 19.

PMID:
28110987
5.

Text messaging research participants as a follow-up strategy to decrease emergency department study attrition.

Varner C, McLeod S, Nahiddi N, Borgundvaag B.

CJEM. 2017 Jan 9:1-6. doi: 10.1017/cem.2016.408. [Epub ahead of print]

PMID:
28065207
6.

Prospective and Explicit Clinical Validation of the Ottawa Heart Failure Risk Scale, With and Without Use of Quantitative NT-proBNP.

Stiell IG, Perry JJ, Clement CM, Brison RJ, Rowe BH, Aaron SD, McRae AD, Borgundvaag B, Calder LA, Forster AJ, Wells GA.

Acad Emerg Med. 2017 Mar;24(3):316-327. doi: 10.1111/acem.13141.

PMID:
27976497
7.

Fetal outcomes following emergency department point-of-care ultrasound for vaginal bleeding in early pregnancy.

Varner C, Balaban D, McLeod S, Carver S, Borgundvaag B.

Can Fam Physician. 2016 Jul;62(7):572-578. Erratum in: Can Fam Physician. ;62(8):628.

8.

Acquisition of bacteria on health care workers' hands after contact with patient privacy curtains.

Larocque M, Carver S, Bertrand A, McGeer A, McLeod S, Borgundvaag B.

Am J Infect Control. 2016 Nov 1;44(11):1385-1386. doi: 10.1016/j.ajic.2016.04.227. Epub 2016 Jul 4.

PMID:
27388269
9.

Predictors of influenza among older adults in the emergency department.

Lam PP, Coleman BL, Green K, Powis J, Richardson D, Katz K, Borgundvaag B, Smith-Gorvie T, Kwong JC, Bondy SJ, McGeer A.

BMC Infect Dis. 2016 Oct 28;16(1):615.

10.

Cognitive Rest and Graduated Return to Usual Activities Versus Usual Care for Mild Traumatic Brain Injury: A Randomized Controlled Trial of Emergency Department Discharge Instructions.

Varner CE, McLeod S, Nahiddi N, Lougheed RE, Dear TE, Borgundvaag B.

Acad Emerg Med. 2017 Jan;24(1):75-82. doi: 10.1111/acem.13073.

PMID:
27792852
11.

Efficacy of Early Invasive Management After Fibrinolysis for ST-Segment Elevation Myocardial Infarction in Relation to Initial Troponin Status.

Tan NS, Goodman SG, Cantor WJ, Russo JJ, Borgundvaag B, Fitchett D, Džavík V, Tan MK, Elbarouni B, Lavi S, Bagai A, Heffernan M, Ko DT, Yan AT.

Can J Cardiol. 2016 Oct;32(10):1221.e11-1221.e18. doi: 10.1016/j.cjca.2016.01.010. Epub 2016 Jan 21.

PMID:
26975225
12.

A quantitative evaluation of alcohol withdrawal tremors.

Aarabi P, Norouzi N, Dear T, Carver S, Bromberg S, Gray S, Kahan M, Borgundvaag B.

Conf Proc IEEE Eng Med Biol Soc. 2015;2015:6215-8. doi: 10.1109/EMBC.2015.7319812.

PMID:
26737712
13.

Closing the circle of care: implementation of a web-based communication tool to improve emergency department discharge communication with family physicians.

Hunchak C, Tannenbaum D, Roberts M, Shah T, Tisma P, Ovens H, Borgundvaag B.

CJEM. 2015 Mar;17(2):123-30. doi: 10.2310/8000.2014.141327.

PMID:
25927256
14.

Efficacy and safety of a routine early invasive strategy in relation to time from symptom onset to fibrinolysis (a subgroup analysis of TRANSFER-AMI).

Russo JJ, Goodman SG, Cantor WJ, Tan MK, Borgundvaag B, Fitchett D, Džavík V, Yan RT, Graham JJ, Mehta SR, Yan AT; TRANSFER-AMI Investigators.

Am J Cardiol. 2015 Apr 15;115(8):1005-12. doi: 10.1016/j.amjcard.2015.01.533. Epub 2015 Jan 31.

PMID:
25711435
15.

Time-frequency visualization of alcohol withdrawal tremors.

Carver S, Norouzi N, Bromberg S, Gray S, Kahan M, Aarabi P, Borgundvaag B.

Conf Proc IEEE Eng Med Biol Soc. 2014;2014:5474-7. doi: 10.1109/EMBC.2014.6944865.

PMID:
25571233
16.

Efficacy of an early invasive strategy after fibrinolysis in ST-elevation myocardial infarction relative to the extent of coronary artery disease.

Elbarouni B, Cantor WJ, Ducas J, Borgundvaag B, Džavík V, Heffernan M, Buller CE, Langer A, Goodman SG, Yan AT; TRANSFER-AMI Trial Investigators.

Can J Cardiol. 2014 Dec;30(12):1555-61. doi: 10.1016/j.cjca.2014.09.001. Epub 2014 Sep 4.

PMID:
25475460
17.

Evaluation of the reproducibility of the Naranjo Adverse Drug Reaction Probability Scale score in published case reports.

Liang R, Borgundvaag B, McIntyre M, Thwaites C, Ragan K, Wyllie A.

Pharmacotherapy. 2014 Nov;34(11):1159-66. doi: 10.1002/phar.1496. Epub 2014 Sep 30.

PMID:
25266970
18.

Clinical characteristics associated with adverse events in patients with exacerbation of chronic obstructive pulmonary disease: a prospective cohort study.

Stiell IG, Clement CM, Aaron SD, Rowe BH, Perry JJ, Brison RJ, Calder LA, Lang E, Borgundvaag B, Forster AJ, Wells GA.

CMAJ. 2014 Apr 1;186(6):E193-204. doi: 10.1503/cmaj.130968. Epub 2014 Feb 18.

19.

Prevalence and incidence of antimicrobial-resistant organisms among hospitalized inflammatory bowel disease patients.

Vaisman A, Pivovarov K, McGeer A, Willey B, Borgundvaag B, Porter V, Gnanasuntharam P, Wei Y, Nguyen GC.

Can J Infect Dis Med Microbiol. 2013 Winter;24(4):e117-21.

20.

Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial.

Russo JJ, Goodman SG, Cantor WJ, Fitchett D, Heffernan M, Borgundvaag B, Ducas J, Cohen EA, Džavik V, Mehta SR, Buller CE, Yan AT; TRANSFER-AMI investigators.

Heart. 2014 Jun;100(11):873-80. doi: 10.1136/heartjnl-2013-305231. Epub 2014 Jan 21.

PMID:
24449716

Supplemental Content

Loading ...
Support Center